Terri B. Sebree
2018
In 2018, Terri B. Sebree earned a total compensation of $1.3M as President at Zynerba Pharmaceuticals, a 20% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $227,849 |
|---|---|
| Option Awards | $590,606 |
| Salary | $437,750 |
| Other | $24,826 |
| Total | $1,281,031 |
Sebree received $590.6K in option awards, accounting for 46% of the total pay in 2018.
Sebree also received $227.8K in non-equity incentive plan, $437.8K in salary and $24.8K in other compensation.
Rankings
In 2018, Terri B. Sebree's compensation ranked 7,960th out of 14,244 executives tracked by ExecPay. In other words, Sebree earned more than 44.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,960 out of 14,244 | 44th |
Division Manufacturing | 3,125 out of 5,759 | 46th |
Major group Chemicals And Allied Products | 1,165 out of 2,122 | 45th |
Industry group Drugs | 978 out of 1,811 | 46th |
Industry Pharmaceutical Preparations | 759 out of 1,385 | 45th |
Source: SEC filing on April 25, 2019.
Sebree's colleagues
We found two more compensation records of executives who worked with Terri B. Sebree at Zynerba Pharmaceuticals in 2018.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019